Multicenter, Open-label, Controlled, Randomized Clinical Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2019
Price : $35 *
At a glance
- Drugs Racecadotril (Primary)
- Indications Diarrhoea
- Focus Registrational; Therapeutic Use
- Sponsors Abbott Laboratories
- 26 Sep 2018 Status changed from recruiting to completed.
- 12 Jun 2018 Status changed from not yet recruiting to recruiting.
- 21 Mar 2018 Planned initiation date changed from 15 Mar 2018 to 13 Apr 2018.